Clinical trial
The Ischemia Modified Albumin In Diagnosing Ischemic New Events
NCT00355992 · Inverness Medical Innovations, Industry · Terminated
Key facts
| NCT number | NCT00355992 |
|---|---|
| Title | The Ischemia Modified Albumin In Diagnosing Ischemic New Events |
| Official title | The Ischemia Modified Albumin In Diagnosing Ischemic New Events (IMAGINE Study). |
| Acronym | IMAgine |
| Lead sponsor | Inverness Medical Innovations, Industry |
| Status | Terminated |
| Study type | Observational |
| Conditions | Heart Disease, Ischemic, Ischemia, Myocardial, Ischemic Heart Disease, Unstable Angina |
| Enrollment | 1,250 |
| Start date | Sep 1, 2006 |
| Completion | Dec 1, 2007 |
| First posted | Jul 25, 2006 |
| Last update posted | May 12, 2009 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: